Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection

Figure 2

Anti-IFN-γ autoantibody titers of responsive patients after stopping IVCY pulse therapy. Median anti-IFN-γ autoantibody titers in plasma from responsive patients () were followed for 1 year at different time points after stopping IVCY pulse therapy. Statistical significance was determined using ANOVA with Dunnett’s multiple comparisons test; ns: nonsignificant.